top of page
IMG_1937_edited.jpg

Frequently Asked Questions

I'm interested in working with psilocybin or MDMA. Can you administer psychedelic-assisted therapy with either of these substances or refer me to someone who provides it?

While there are a number of promising studies on the clinical potential of psychedelics, these substances (with the exception of ketamine) are currently illegal outside of the research setting in the United States. As a result, I do not work with them in my private practice nor do I provide referrals. 

But I thought that psilocybin is legal in Cambridge.

The growth of psilocybin-containing mushrooms for personal use has been decriminalized in Cambridge, but psilocybin remains federally illegal outside the research setting.

Can you prescribe me medical cannabis?

No, I cannot.

Can you help me enroll in a clinical trial of psychedelic-assisted therapy?

I am not currently involved in any clinical trials that are recruiting new subjects. For more information regarding current and past clinical trials, please go to: 

 https://www.clinicaltrials.gov/

I'm considering working with psychedelic substances on my own and I'd like assistance preparing for and integrating the experience. Can you help with this?

While I cannot recommend that you use these substances outside of a research setting, I can discuss with you the currently-available evidence base for psychedelics, as well as the inclusion and exclusion criteria used in psychedelics-related clinical research, in order to help you make an informed decision about if, when, and how to use these substances. I can also work with you to adjust your psychiatric medication regimen in order to minimize any possible interactions with psychedelics, and I can work with you in psychotherapy to help prepare for and integrate these experiences.

Can you provide me with Ketamine-Assisted Psychotherapy for my own personal growth and wellness?

Since ketamine is a controlled substance, it can only be provided to individuals for treatment of a diagnosed illness. Ketamine has not yet been approved by the FDA for any mental health indications. I offer "off-label" Ketamine-Assisted Psychotherapy for indications with an evidence base to support them, including: depression (both unipolar and bipolar) refractory to other medications, OCD and related disorders, and pain-related mood disorders.

Why do you offer treatment with regular ketamine instead of Spravato? 

Spravato (generic name: esketamine) is a proprietary derivative of regular ketamine that received FDA approval for treatment-resistant depression despite failing to demonstrate efficacy greater than placebo in two out of three large-scale prospective clinical trials. Because it is a proprietary compound, it is significantly more expensive than regular ketamine. Additionally, meta-analyses and small head-to-head trials suggest that regular ketamine may in fact be superior to esketamine in treating mood disorders. I have written about these issues previously.

I am a mid-level provider looking for an MD to supervise my clinical practice. Do you offer this?

Unfortunately, I do not offer this service.

bottom of page